597 related articles for article (PubMed ID: 15196705)
21. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.
Hackett RH; Wang YD; Sweitzer S; Feldman G; Wood WI; Larner AC
J Biol Chem; 1997 Apr; 272(17):11128-32. PubMed ID: 9111009
[TBL] [Abstract][Full Text] [Related]
22. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway.
Ji S; Guan R; Frank SJ; Messina JL
J Biol Chem; 1999 May; 274(19):13434-42. PubMed ID: 10224108
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts.
King AP; Carter-Su C
Endocrinology; 1995 Nov; 136(11):4796-803. PubMed ID: 7588209
[TBL] [Abstract][Full Text] [Related]
24. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
VanderKuur JA; Wang X; Zhang L; Campbell GS; Allevato G; Billestrup N; Norstedt G; Carter-Su C
J Biol Chem; 1994 Aug; 269(34):21709-17. PubMed ID: 8063815
[TBL] [Abstract][Full Text] [Related]
25. Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization.
Zhang Y; Jiang J; Kopchick JJ; Frank SJ
J Biol Chem; 1999 Nov; 274(46):33072-84. PubMed ID: 10551877
[TBL] [Abstract][Full Text] [Related]
26. Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.
Kanzaki M; Morris PL
Endocrinology; 1998 Apr; 139(4):1872-82. PubMed ID: 9528973
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Feb; 13(2):213-27. PubMed ID: 9973252
[TBL] [Abstract][Full Text] [Related]
28. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
Ram PA; Waxman DJ
J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
[TBL] [Abstract][Full Text] [Related]
30. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes.
Eriksson H; Ridderstråle M; Tornqvist H
Endocrinology; 1995 Nov; 136(11):5093-101. PubMed ID: 7588246
[TBL] [Abstract][Full Text] [Related]
32. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Hsieh TC; Wu JM
Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
[TBL] [Abstract][Full Text] [Related]
33. Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.
Sustarsic EG; Junnila RK; Kopchick JJ
Biochem Biophys Res Commun; 2013 Nov; 441(1):144-50. PubMed ID: 24134847
[TBL] [Abstract][Full Text] [Related]
34. A beta-turn endocytic code is required for optimal internalization of the growth hormone receptor but not for alpha-adaptin association.
Vleurick L; Pezet A; Kühn ER; Decuypere E; Edery M
Mol Endocrinol; 1999 Nov; 13(11):1823-31. PubMed ID: 10551776
[TBL] [Abstract][Full Text] [Related]
35. Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity.
Stred SE; Stubbart JR; Argetsinger LS; Smith WC; Shafer JA; Talamantes F; Carter-Su C
Endocrinology; 1992 Mar; 130(3):1626-36. PubMed ID: 1537311
[TBL] [Abstract][Full Text] [Related]
36. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
Sotiropoulos A; Perrot-Applanat M; Dinerstein H; Pallier A; Postel-Vinay MC; Finidori J; Kelly PA
Endocrinology; 1994 Oct; 135(4):1292-8. PubMed ID: 7925092
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription.
Goh EL; Pircher TJ; Wood TJ; Norstedt G; Graichen R; Lobie PE
Endocrinology; 1997 Aug; 138(8):3207-15. PubMed ID: 9231769
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling.
Yarwood SJ; Sale EM; Sale GJ; Houslay MD; Kilgour E; Anderson NG
J Biol Chem; 1999 Mar; 274(13):8662-8. PubMed ID: 10085104
[TBL] [Abstract][Full Text] [Related]
39. Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells.
Silva CM; Day RN; Weber MJ; Thorner MO
Endocrinology; 1993 Nov; 133(5):2307-12. PubMed ID: 7691587
[TBL] [Abstract][Full Text] [Related]
40. Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway.
Costoya JA; Finidori J; Moutoussamy S; Seãris R; Devesa J; Arce VM
Endocrinology; 1999 Dec; 140(12):5937-43. PubMed ID: 10579361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
